<DOC>
	<DOC>NCT00993070</DOC>
	<brief_summary>Painful diabetic neuropathy is the most common cause of neuropathic pain. 0.075% topical capsaicin has been used to treat the pain, but there is no data in lower concentration. This is the efficacy and safety of 0.025% topical capsaicin in treatment of painful diabetic polyneuropathy.</brief_summary>
	<brief_title>Efficacy and Safety Study of Topical Capsaicin in Painful Diabetic Neuropathy</brief_title>
	<detailed_description>Patient is randomized to receive either 0.025% topical capsaicin or vehicle control (placebo) for 8 weeks. After one week wash-out period, patients will be switched to the other group for 8 weeks. Outcome will be assessed by visual analog scale, neuropathic pain scale, SF-MPQ, SF-36. Safety and tolerability will be recorded.</detailed_description>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>History of type 2 Diabetes mellitus Peripheral neuropathy Stabilized on pain medication for at least one month No previous invasive intervention for pain relief Local wound or skin abnormality in the applicable area Allergic to capsaicin Refuse to participate or give consent Has other significant disease or receive medication that may worsen neuropathy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>capsaicin</keyword>
	<keyword>placebo</keyword>
	<keyword>trial</keyword>
	<keyword>diabetic polyneuropathy</keyword>
	<keyword>neuropathic pain</keyword>
</DOC>